Michael Robin Reich, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Politics | 15 | 2023 | 790 | 3.240 |
Why?
|
| National Health Programs | 9 | 2020 | 445 | 2.390 |
Why?
|
| Chagas Disease | 5 | 2020 | 166 | 1.950 |
Why?
|
| Health Policy | 19 | 2023 | 2657 | 1.930 |
Why?
|
| Government Programs | 3 | 2022 | 275 | 1.420 |
Why?
|
| Trypanocidal Agents | 4 | 2020 | 38 | 1.410 |
Why?
|
| Health Care Reform | 10 | 2020 | 1261 | 1.380 |
Why?
|
| Developing Countries | 17 | 2018 | 2789 | 1.330 |
Why?
|
| Nitroimidazoles | 4 | 2020 | 106 | 1.320 |
Why?
|
| Tropical Medicine | 4 | 2018 | 49 | 1.170 |
Why?
|
| Public-Private Sector Partnerships | 2 | 2018 | 120 | 0.950 |
Why?
|
| Private Sector | 8 | 2018 | 390 | 0.950 |
Why?
|
| Health Services Accessibility | 14 | 2018 | 5133 | 0.930 |
Why?
|
| Health Care Sector | 4 | 2019 | 194 | 0.840 |
Why?
|
| Drug Costs | 5 | 2020 | 1104 | 0.780 |
Why?
|
| Drugs, Essential | 3 | 2016 | 73 | 0.760 |
Why?
|
| Disasters | 4 | 2015 | 510 | 0.740 |
Why?
|
| Nutrition Policy | 2 | 2014 | 488 | 0.730 |
Why?
|
| Policy Making | 4 | 2019 | 554 | 0.720 |
Why?
|
| Japan | 10 | 2021 | 1360 | 0.690 |
Why?
|
| Delivery of Health Care | 7 | 2019 | 5304 | 0.690 |
Why?
|
| Mexico | 7 | 2022 | 688 | 0.680 |
Why?
|
| Economics | 1 | 2019 | 146 | 0.650 |
Why?
|
| Public Sector | 6 | 2018 | 264 | 0.620 |
Why?
|
| Quality of Health Care | 3 | 2020 | 4369 | 0.620 |
Why?
|
| Infectious Disease Medicine | 1 | 2018 | 46 | 0.610 |
Why?
|
| International Cooperation | 9 | 2015 | 1421 | 0.610 |
Why?
|
| Government | 1 | 2018 | 165 | 0.600 |
Why?
|
| Social Responsibility | 2 | 2018 | 389 | 0.550 |
Why?
|
| Health Care Rationing | 1 | 2019 | 435 | 0.540 |
Why?
|
| Public Health Nursing | 2 | 2014 | 15 | 0.520 |
Why?
|
| Accidents, Traffic | 4 | 2007 | 819 | 0.520 |
Why?
|
| Maternal Health Services | 1 | 2020 | 452 | 0.510 |
Why?
|
| Papillomavirus Vaccines | 1 | 2021 | 489 | 0.510 |
Why?
|
| Food Supply | 3 | 2014 | 517 | 0.490 |
Why?
|
| Economic Competition | 2 | 2015 | 214 | 0.490 |
Why?
|
| Conservation of Natural Resources | 1 | 2016 | 205 | 0.490 |
Why?
|
| Leadership | 3 | 2023 | 1357 | 0.460 |
Why?
|
| Health Priorities | 5 | 2013 | 379 | 0.460 |
Why?
|
| Antiprotozoal Agents | 1 | 2013 | 86 | 0.450 |
Why?
|
| Health Expenditures | 3 | 2016 | 2346 | 0.450 |
Why?
|
| Interinstitutional Relations | 2 | 2006 | 240 | 0.450 |
Why?
|
| Disclosure | 2 | 2018 | 736 | 0.450 |
Why?
|
| Prenatal Care | 1 | 2020 | 1088 | 0.440 |
Why?
|
| Public Health | 7 | 2023 | 2594 | 0.430 |
Why?
|
| Research | 6 | 2018 | 1999 | 0.410 |
Why?
|
| Drug Industry | 7 | 2018 | 744 | 0.400 |
Why?
|
| Policy | 1 | 2015 | 504 | 0.400 |
Why?
|
| Life Expectancy | 3 | 2015 | 1183 | 0.390 |
Why?
|
| Information Dissemination | 2 | 2018 | 1100 | 0.380 |
Why?
|
| Drugs, Generic | 1 | 2015 | 422 | 0.370 |
Why?
|
| Pharmaceutical Preparations | 7 | 2015 | 1071 | 0.360 |
Why?
|
| Papillomavirus Infections | 1 | 2021 | 1585 | 0.350 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2020 | 2026 | 0.330 |
Why?
|
| Public Health Administration | 2 | 2002 | 239 | 0.330 |
Why?
|
| Orphan Drug Production | 1 | 2009 | 50 | 0.320 |
Why?
|
| Health Status | 2 | 2011 | 4030 | 0.310 |
Why?
|
| Malaria | 1 | 2018 | 1232 | 0.310 |
Why?
|
| World Health Organization | 5 | 2019 | 1317 | 0.290 |
Why?
|
| Biomedical Technology | 1 | 2009 | 221 | 0.290 |
Why?
|
| Congresses as Topic | 2 | 2009 | 764 | 0.280 |
Why?
|
| Preventive Health Services | 1 | 2011 | 575 | 0.280 |
Why?
|
| Humans | 66 | 2023 | 742088 | 0.280 |
Why?
|
| Counseling | 1 | 2014 | 1521 | 0.270 |
Why?
|
| Ethics, Institutional | 2 | 2003 | 37 | 0.270 |
Why?
|
| Drugs, Investigational | 2 | 2020 | 214 | 0.270 |
Why?
|
| Patient-Centered Care | 1 | 2016 | 1436 | 0.260 |
Why?
|
| Relief Work | 2 | 1999 | 137 | 0.260 |
Why?
|
| Internationality | 2 | 2000 | 1002 | 0.240 |
Why?
|
| Nifurtimox | 2 | 2015 | 13 | 0.240 |
Why?
|
| Population Dynamics | 2 | 2011 | 301 | 0.240 |
Why?
|
| Public Health Practice | 1 | 2006 | 217 | 0.230 |
Why?
|
| Telemedicine | 1 | 2020 | 2853 | 0.220 |
Why?
|
| Republic of Korea | 2 | 2015 | 538 | 0.220 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3130 | 0.210 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3236 | 0.210 |
Why?
|
| Physician-Patient Relations | 1 | 2016 | 3215 | 0.210 |
Why?
|
| Models, Organizational | 4 | 2010 | 574 | 0.210 |
Why?
|
| Ethical Analysis | 1 | 2002 | 42 | 0.210 |
Why?
|
| Organizations | 3 | 2018 | 170 | 0.210 |
Why?
|
| Health Care Costs | 1 | 2015 | 3203 | 0.210 |
Why?
|
| Program Development | 3 | 2019 | 1314 | 0.210 |
Why?
|
| Wounds and Injuries | 3 | 2003 | 2400 | 0.200 |
Why?
|
| Communicable Disease Control | 1 | 2008 | 854 | 0.200 |
Why?
|
| Parents | 2 | 2014 | 3387 | 0.190 |
Why?
|
| Environmental Exposure | 1 | 2015 | 4231 | 0.190 |
Why?
|
| Pandemics | 1 | 2020 | 8328 | 0.180 |
Why?
|
| Madagascar | 1 | 2020 | 117 | 0.180 |
Why?
|
| Program Evaluation | 4 | 2018 | 2485 | 0.170 |
Why?
|
| Primary Health Care | 1 | 2016 | 4551 | 0.170 |
Why?
|
| Cooperative Behavior | 4 | 2018 | 1503 | 0.170 |
Why?
|
| State Government | 1 | 2002 | 369 | 0.170 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2000 | 282 | 0.170 |
Why?
|
| Reproductive Rights | 1 | 2018 | 35 | 0.160 |
Why?
|
| Praziquantel | 1 | 1998 | 25 | 0.160 |
Why?
|
| Drug Stability | 1 | 1999 | 290 | 0.160 |
Why?
|
| Trypanosoma cruzi | 1 | 2020 | 198 | 0.160 |
Why?
|
| Legislation, Drug | 1 | 2000 | 206 | 0.160 |
Why?
|
| Schistosomiasis | 1 | 1998 | 62 | 0.160 |
Why?
|
| Anthelmintics | 1 | 1998 | 62 | 0.150 |
Why?
|
| Culicidae | 1 | 2018 | 104 | 0.150 |
Why?
|
| Drug and Narcotic Control | 2 | 2000 | 146 | 0.150 |
Why?
|
| Mosquito Control | 1 | 2018 | 104 | 0.150 |
Why?
|
| Trust | 1 | 2021 | 501 | 0.150 |
Why?
|
| India | 2 | 2022 | 2187 | 0.140 |
Why?
|
| Drug Labeling | 1 | 1999 | 231 | 0.140 |
Why?
|
| Ethics, Medical | 1 | 2002 | 791 | 0.140 |
Why?
|
| Birth Rate | 2 | 2015 | 170 | 0.140 |
Why?
|
| Public Policy | 2 | 1994 | 572 | 0.140 |
Why?
|
| Haemophilus Vaccines | 1 | 2016 | 69 | 0.140 |
Why?
|
| Staff Development | 1 | 2018 | 223 | 0.130 |
Why?
|
| Legislation, Pharmacy | 1 | 1995 | 2 | 0.130 |
Why?
|
| Chronic Disease | 1 | 2010 | 9144 | 0.130 |
Why?
|
| Pregnant Women | 1 | 2020 | 566 | 0.130 |
Why?
|
| Social Security | 1 | 2015 | 100 | 0.130 |
Why?
|
| Bacterial Capsules | 1 | 2016 | 251 | 0.130 |
Why?
|
| Latin America | 1 | 2016 | 381 | 0.120 |
Why?
|
| Radiation Monitoring | 1 | 2015 | 97 | 0.120 |
Why?
|
| Motor Vehicles | 3 | 2007 | 268 | 0.120 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 20774 | 0.120 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2020 | 3014 | 0.120 |
Why?
|
| Tsunamis | 1 | 2014 | 59 | 0.120 |
Why?
|
| State Medicine | 1 | 2015 | 220 | 0.120 |
Why?
|
| Rural Health | 1 | 2015 | 305 | 0.120 |
Why?
|
| Child Health Services | 1 | 1999 | 667 | 0.120 |
Why?
|
| HIV Infections | 3 | 2006 | 16678 | 0.110 |
Why?
|
| Immunization Programs | 1 | 2016 | 259 | 0.110 |
Why?
|
| Anti-Infective Agents | 1 | 2001 | 971 | 0.110 |
Why?
|
| Taxes | 1 | 2015 | 221 | 0.110 |
Why?
|
| Blood Donors | 1 | 2015 | 355 | 0.110 |
Why?
|
| Administrative Personnel | 1 | 2014 | 187 | 0.110 |
Why?
|
| Female | 15 | 2022 | 379592 | 0.110 |
Why?
|
| Urban Health | 1 | 2015 | 547 | 0.110 |
Why?
|
| Health Planning | 1 | 2014 | 237 | 0.110 |
Why?
|
| United States Food and Drug Administration | 1 | 2020 | 1581 | 0.110 |
Why?
|
| Botswana | 2 | 2006 | 1040 | 0.100 |
Why?
|
| Goals | 2 | 2015 | 705 | 0.100 |
Why?
|
| Earthquakes | 1 | 2014 | 179 | 0.100 |
Why?
|
| Schools, Public Health | 1 | 1991 | 22 | 0.100 |
Why?
|
| Poverty | 5 | 2009 | 2646 | 0.100 |
Why?
|
| Public Opinion | 1 | 2015 | 477 | 0.100 |
Why?
|
| Cost Control | 1 | 2013 | 624 | 0.100 |
Why?
|
| Interviews as Topic | 2 | 2016 | 2536 | 0.090 |
Why?
|
| Technology, High-Cost | 1 | 2009 | 32 | 0.090 |
Why?
|
| Costs and Cost Analysis | 1 | 2015 | 1679 | 0.090 |
Why?
|
| Efficiency, Organizational | 1 | 1994 | 695 | 0.090 |
Why?
|
| History, 21st Century | 1 | 2015 | 1533 | 0.090 |
Why?
|
| Pregnancy | 3 | 2020 | 29087 | 0.090 |
Why?
|
| Anti-HIV Agents | 1 | 2005 | 4250 | 0.090 |
Why?
|
| Vaccination | 1 | 2021 | 3256 | 0.080 |
Why?
|
| Government Agencies | 2 | 2008 | 156 | 0.080 |
Why?
|
| Peer Group | 1 | 2014 | 635 | 0.080 |
Why?
|
| Health Care Surveys | 2 | 2015 | 2451 | 0.080 |
Why?
|
| Health Literacy | 1 | 2014 | 414 | 0.080 |
Why?
|
| Home Childbirth | 1 | 1989 | 50 | 0.080 |
Why?
|
| Fraud | 2 | 2002 | 67 | 0.080 |
Why?
|
| Parenting | 1 | 2014 | 676 | 0.080 |
Why?
|
| Infant, Newborn | 4 | 2020 | 25575 | 0.080 |
Why?
|
| Drug Utilization | 2 | 2008 | 1181 | 0.080 |
Why?
|
| Needs Assessment | 1 | 2014 | 1146 | 0.080 |
Why?
|
| Malnutrition | 1 | 2014 | 625 | 0.080 |
Why?
|
| History, 20th Century | 1 | 2015 | 2739 | 0.080 |
Why?
|
| Culture | 1 | 2011 | 632 | 0.070 |
Why?
|
| Insurance, Liability | 1 | 1988 | 102 | 0.070 |
Why?
|
| Occupational Health Services | 1 | 1988 | 154 | 0.070 |
Why?
|
| Seat Belts | 1 | 2007 | 57 | 0.070 |
Why?
|
| Insurance, Health | 2 | 2015 | 2493 | 0.070 |
Why?
|
| Age Factors | 2 | 2020 | 18355 | 0.070 |
Why?
|
| Environmental Pollution | 1 | 1988 | 118 | 0.070 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2021 | 3915 | 0.070 |
Why?
|
| Developed Countries | 2 | 2007 | 436 | 0.070 |
Why?
|
| Forecasting | 1 | 2015 | 2948 | 0.070 |
Why?
|
| Social Class | 1 | 2015 | 1995 | 0.070 |
Why?
|
| Automobiles | 1 | 2007 | 116 | 0.070 |
Why?
|
| Foundations | 1 | 2006 | 94 | 0.070 |
Why?
|
| Risk Assessment | 1 | 2007 | 23320 | 0.060 |
Why?
|
| Transportation | 1 | 2007 | 211 | 0.060 |
Why?
|
| Gene Dosage | 1 | 2010 | 1251 | 0.060 |
Why?
|
| Health Resources | 1 | 1991 | 911 | 0.060 |
Why?
|
| Safety | 2 | 2007 | 1185 | 0.060 |
Why?
|
| Drug Therapy | 2 | 2000 | 497 | 0.060 |
Why?
|
| Rare Diseases | 1 | 2009 | 554 | 0.060 |
Why?
|
| Patient Satisfaction | 1 | 2016 | 3391 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 7276 | 0.060 |
Why?
|
| Bangladesh | 2 | 1995 | 687 | 0.050 |
Why?
|
| Feminism | 1 | 2002 | 6 | 0.050 |
Why?
|
| United States | 5 | 2020 | 69693 | 0.050 |
Why?
|
| Philosophy, Medical | 1 | 2002 | 79 | 0.050 |
Why?
|
| Delphi Technique | 2 | 1996 | 778 | 0.050 |
Why?
|
| International Agencies | 1 | 2002 | 240 | 0.050 |
Why?
|
| Delivery, Obstetric | 1 | 1989 | 904 | 0.050 |
Why?
|
| Bicycling | 1 | 2003 | 176 | 0.050 |
Why?
|
| DNA Copy Number Variations | 1 | 2010 | 1940 | 0.050 |
Why?
|
| Probability | 1 | 2007 | 2502 | 0.050 |
Why?
|
| Male | 8 | 2016 | 349538 | 0.050 |
Why?
|
| Healthcare Disparities | 1 | 2015 | 3151 | 0.040 |
Why?
|
| Communication | 1 | 2014 | 3728 | 0.040 |
Why?
|
| Occupational Diseases | 1 | 1988 | 1472 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 24913 | 0.040 |
Why?
|
| Human Rights | 1 | 2002 | 302 | 0.040 |
Why?
|
| Patents as Topic | 1 | 2000 | 103 | 0.040 |
Why?
|
| Social Change | 1 | 1999 | 153 | 0.040 |
Why?
|
| Walking | 2 | 2003 | 1177 | 0.040 |
Why?
|
| Environmental Pollutants | 1 | 1988 | 1180 | 0.040 |
Why?
|
| Organizational Innovation | 1 | 2002 | 559 | 0.040 |
Why?
|
| Curriculum | 1 | 1991 | 3589 | 0.040 |
Why?
|
| Social Perception | 1 | 2002 | 424 | 0.040 |
Why?
|
| Automobile Driving | 1 | 2003 | 431 | 0.040 |
Why?
|
| Adult | 5 | 2020 | 213712 | 0.040 |
Why?
|
| Social Work | 1 | 2018 | 162 | 0.040 |
Why?
|
| Conflict of Interest | 1 | 2002 | 542 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 2 | 2016 | 5385 | 0.030 |
Why?
|
| Cost of Illness | 2 | 2003 | 1852 | 0.030 |
Why?
|
| School Health Services | 1 | 2000 | 375 | 0.030 |
Why?
|
| Indonesia | 1 | 2016 | 119 | 0.030 |
Why?
|
| Haemophilus Infections | 1 | 2016 | 95 | 0.030 |
Why?
|
| Adolescent | 4 | 2016 | 85649 | 0.030 |
Why?
|
| Socioeconomic Factors | 3 | 2008 | 7770 | 0.030 |
Why?
|
| Philippines | 1 | 1995 | 86 | 0.030 |
Why?
|
| Sri Lanka | 1 | 1995 | 90 | 0.030 |
Why?
|
| Lymphoma, B-Cell | 1 | 2002 | 930 | 0.030 |
Why?
|
| Economics, Pharmaceutical | 1 | 1995 | 87 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2007 | 3584 | 0.030 |
Why?
|
| Italy | 2 | 1994 | 828 | 0.030 |
Why?
|
| Emergency Medical Services | 2 | 2003 | 1914 | 0.030 |
Why?
|
| Prejudice | 1 | 2018 | 569 | 0.030 |
Why?
|
| Systems Analysis | 1 | 2015 | 171 | 0.030 |
Why?
|
| Infant | 3 | 2014 | 35070 | 0.030 |
Why?
|
| Child, Preschool | 3 | 2014 | 40955 | 0.030 |
Why?
|
| Financial Management | 1 | 1994 | 160 | 0.030 |
Why?
|
| Middle Aged | 3 | 2016 | 213127 | 0.030 |
Why?
|
| Social Stigma | 1 | 2018 | 698 | 0.030 |
Why?
|
| Health Education | 1 | 2018 | 1053 | 0.030 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2002 | 1377 | 0.030 |
Why?
|
| Evidence-Based Practice | 1 | 2016 | 500 | 0.020 |
Why?
|
| Child | 5 | 2003 | 77478 | 0.020 |
Why?
|
| Motivation | 1 | 2000 | 1968 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 57683 | 0.020 |
Why?
|
| Research Personnel | 1 | 2014 | 573 | 0.020 |
Why?
|
| Nurse Midwives | 1 | 1989 | 23 | 0.020 |
Why?
|
| Hospitalization | 1 | 1989 | 10232 | 0.020 |
Why?
|
| AIDS Vaccines | 1 | 1996 | 938 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2015 | 77098 | 0.020 |
Why?
|
| Universities | 1 | 2014 | 953 | 0.020 |
Why?
|
| Labor Unions | 1 | 1988 | 47 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2002 | 2187 | 0.020 |
Why?
|
| bcl-X Protein | 1 | 2010 | 411 | 0.020 |
Why?
|
| Fees, Pharmaceutical | 1 | 2008 | 64 | 0.020 |
Why?
|
| Workers' Compensation | 1 | 1988 | 152 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2016 | 2680 | 0.020 |
Why?
|
| Self Medication | 1 | 2008 | 117 | 0.020 |
Why?
|
| Risk Factors | 3 | 2003 | 72145 | 0.020 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1996 | 2231 | 0.020 |
Why?
|
| Accidents, Occupational | 1 | 1988 | 251 | 0.020 |
Why?
|
| Multigene Family | 1 | 2010 | 1102 | 0.020 |
Why?
|
| Animals | 1 | 2018 | 168561 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2002 | 9410 | 0.020 |
Why?
|
| Gene Amplification | 1 | 2010 | 1062 | 0.020 |
Why?
|
| Prescriptions | 1 | 2008 | 387 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2018 | 3839 | 0.020 |
Why?
|
| Incidence | 1 | 2003 | 20928 | 0.020 |
Why?
|
| Community Mental Health Services | 1 | 1988 | 386 | 0.020 |
Why?
|
| Social Support | 1 | 2014 | 2117 | 0.020 |
Why?
|
| Pediatrics | 1 | 1999 | 3462 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2000 | 3306 | 0.020 |
Why?
|
| Netherlands | 1 | 1989 | 2170 | 0.010 |
Why?
|
| Infant Mortality | 1 | 1989 | 754 | 0.010 |
Why?
|
| Health Services Research | 1 | 1991 | 1834 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2010 | 1434 | 0.010 |
Why?
|
| Aged | 1 | 2015 | 162944 | 0.010 |
Why?
|
| Motorcycles | 1 | 2003 | 44 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 2015 | 3527 | 0.010 |
Why?
|
| Neoplasms | 1 | 2010 | 21596 | 0.010 |
Why?
|
| Egypt | 1 | 2000 | 100 | 0.010 |
Why?
|
| Cell Survival | 1 | 2010 | 5872 | 0.010 |
Why?
|
| Vincristine | 1 | 2002 | 1036 | 0.010 |
Why?
|
| Dominican Republic | 1 | 1999 | 76 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2015 | 4681 | 0.010 |
Why?
|
| Guideline Adherence | 1 | 2008 | 2266 | 0.010 |
Why?
|
| Health Benefit Plans, Employee | 1 | 2000 | 332 | 0.010 |
Why?
|
| Prednisone | 1 | 2002 | 1567 | 0.010 |
Why?
|
| Health Plan Implementation | 1 | 2000 | 351 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 2002 | 2236 | 0.010 |
Why?
|
| Switzerland | 1 | 1996 | 254 | 0.010 |
Why?
|
| Child Welfare | 1 | 2000 | 523 | 0.010 |
Why?
|
| Office Visits | 1 | 2000 | 598 | 0.010 |
Why?
|
| Doxorubicin | 1 | 2002 | 2215 | 0.010 |
Why?
|
| Genomics | 1 | 2010 | 5692 | 0.010 |
Why?
|
| Apoptosis | 1 | 2010 | 9715 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 16665 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2002 | 3920 | 0.010 |
Why?
|
| Time Factors | 1 | 2014 | 40054 | 0.010 |
Why?
|
| Insurance Coverage | 1 | 2000 | 1895 | 0.000 |
Why?
|
| Regional Health Planning | 1 | 1988 | 97 | 0.000 |
Why?
|
| Signal Transduction | 1 | 2010 | 23387 | 0.000 |
Why?
|
| Hospitals, Psychiatric | 1 | 1988 | 332 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 2002 | 15056 | 0.000 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2002 | 11472 | 0.000 |
Why?
|
| Health Services Needs and Demand | 1 | 1988 | 1411 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2002 | 62966 | 0.000 |
Why?
|